| __timestamp | Supernus Pharmaceuticals, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72471000 | 7751000 |
| Thursday, January 1, 2015 | 89204000 | 10251000 |
| Friday, January 1, 2016 | 106010000 | 9575000 |
| Sunday, January 1, 2017 | 137905000 | 10912000 |
| Monday, January 1, 2018 | 159888000 | 11049000 |
| Tuesday, January 1, 2019 | 158425000 | 11646000 |
| Wednesday, January 1, 2020 | 200677000 | 13265000 |
| Friday, January 1, 2021 | 304759000 | 25805000 |
| Saturday, January 1, 2022 | 377221000 | 35182000 |
| Sunday, January 1, 2023 | 336361000 | 94999000 |
In pursuit of knowledge
In the competitive landscape of biopharmaceuticals, effective cost management is crucial. Supernus Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. offer a compelling study in contrasts over the past decade. From 2014 to 2023, Supernus Pharmaceuticals saw a staggering 364% increase in SG&A expenses, peaking in 2022. This growth reflects their aggressive expansion and investment in market presence. In contrast, Viridian Therapeutics, while experiencing a 1,126% rise, started from a much smaller base, indicating a strategic scaling of operations. Notably, 2023 marked a significant leap for Viridian, with expenses surging by 170% from the previous year, suggesting a pivotal shift in their business strategy. These trends underscore the dynamic nature of the biopharma sector, where strategic financial management can dictate market success.
Eli Lilly and Company vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? AbbVie Inc. or Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Insmed Incorporated or Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Pharming Group N.V. or Supernus Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of CRISPR Therapeutics AG and Viridian Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Amicus Therapeutics, Inc. and Viridian Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of HUTCHMED (China) Limited and Viridian Therapeutics, Inc.
Comparing SG&A Expenses: Supernus Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc. Trends and Insights
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.